Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Amarna Therapeutics

Request full access

Uses a viral platform to deliver transgenes into humans

Leiden, NetherlandsFounded 2008Biotech & Life Sciences

About Amarna Therapeutics

Amarna Therapeutics, founded in 2008, is a privately held biotech company specializing in the development of the SVac viral gene delivery vector platform. This platform is designed to transform the treatment landscape across various disease areas, including autoimmune disorders and other significant health conditions. The SVac platform is known for its safety, high efficiency, and non-immunogenic properties, making it a groundbreaking tool in the field of gene and immune therapies. The company operates in the biotech sector, primarily serving pharmaceutical companies, research institutions, and healthcare providers looking for advanced gene therapy solutions. Amarna's business model revolves around the development and licensing of its SVac platform, generating revenue through partnerships, collaborations, and licensing agreements. The SVac platform's cost-effective production in the SuperVero packaging cell line further enhances its commercial viability.

Source: Dealroom company data

Amarna Therapeutics in the Leiden ecosystem

Live from Dealroom

The Amarna Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Eureka

Series A1 investor entered at this stage

  • Flerie Invest

Series B and later2 investors entered at this stage

  • Flerie Make investments AB
  • C4 holding BV
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇳🇱 Netherlands76.9%
🇨🇭 Switzerland15.4%
🇪🇸 Spain7.7%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Amarna Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Amarna Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.